At a glance
ClinicalIndex Comparison RecordN/ACompleted· 450 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Human Lipoprotein Pathophysiology - Subproject: Genetics of Familial Combined Hyperlipidemia
In Brief
An observational study for Atherosclerosis and 4 related conditions. Completed, enrolled 450 participants.
Detailed Summary
To conduct focused studies of lipoprotein physiology and pathophysiology in genetically characterized patients with the objectives of understanding disease mechanisms, developing better treatments, and identifying and preventing early vascular disease.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAtherosclerosis, Cardiovascular Diseases, Heart Diseases, Hypercholesterolemia, Hyperlipidemia, Familial Combined
Countries--
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)
Timeline
N/ACompletedFinished
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 2000
Enrollment StartApr 2001
Primary CompletionMar 2003
TodayJul 2026
First PostedMay 26, 2000
Enrollment StartApr 1, 2001
Primary CompletionMar 1, 2003
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 26.1 years ago